Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
61
Number of overlapping holdings
98.4%
% of XLV's 62 holdings also in RSPH
100.0%
% of RSPH's 61 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus RSPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in RSPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 2.2% | 2.0% | 2.0% |
|
GILEAD SCIENCES INC | 2.2% | 1.9% | 1.9% |
|
INTUITIVE SURGICAL INC | 3.7% | 1.9% | 1.9% |
|
BOSTON SCIENTIFIC CORP | 2.6% | 1.9% | 1.9% |
|
STRYKER CORP | 2.5% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to RSPH
|
ELI LILLY & CO | 10.6% |
|
UNITEDHEALTH GROUP INC | 7.8% |
|
JOHNSON & JOHNSON | 5.3% |
|
ABBVIE INC | 4.4% |
|
MERCK & CO. INC. | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
ABBOTT LABORATORIES | 2.1% |
|
INTUITIVE SURGICAL INC | 1.8% |
|
DANAHER CORP | 1.4% |
|
AMGEN INC | 1.4% |
XLV Underweight Relative to RSPH
|
HENRY SCHEIN INC | -1.7% |
|
INCYTE CORP | -1.7% |
|
INSULET CORP | -1.6% |
|
CATALENT INC | -1.6% |
|
VIATRIS, INC. | -1.6% |
|
WATERS CORP | -1.6% |
|
BIO-TECHNE CORPORATION | -1.5% |
|
DAVITA INC | -1.5% |
|
CHARLES RIVER LABORATORIES | -1.5% |
|
WEST PHARMACEUTICAL SERVICES | -1.4% |